We are live on ! Find out more
CPH

C Partners Holding Portfolio holdings

AUM $317M
1-Year Est. Return 4.76%
This Fund
S&P 500
This Quarter Est. Return
-8.49%
1 Year Est. Return
-4.76%
3 Year Est. Return
+31.57%
5 Year Est. Return
+26.92%
10 Year Est. Return
+222.73%
AUM
$181M
AUM Growth
-$32.1M
Cap. Flow
-$8.44M
Cap. Flow %
-4.65%
Top 10 Hldgs %
83.13%
Holding
44
New
1
Increased
2
Reduced
1
Closed
26

Top Sells

Rank Stock Value
1
ADMS
Adamas Pharmaceuticals
ADMS
+$3.69M
2
CELG
Celgene Corp
CELG
+$3.59M
3
JNJ icon
Johnson & Johnson
JNJ
+$2.93M
4
VTRS icon
Viatris
VTRS
+$2.6M
5
ABT icon
Abbott
ABT
+$2.56M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 8.24%
2 Materials 6.04%
3 Consumer Staples 5.29%
4 Financials 5.23%
5 Industrials 4.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GLD icon
1
SPDR Gold Trust
GLD
$131B
$55.6M 30.69%
520,600
CFMS
2
DELISTED
Conformis, Inc. Common Stock
CFMS
$26.4M 14.57%
+58,506
New +$29.5M
ADMS
3
DELISTED
Adamas Pharmaceuticals
ADMS
$22M 12.12%
1,312,128
-162,354
-11% -$3.69M
ICE icon
4
Intercontinental Exchange
ICE
$85.6B
$9.48M 5.23%
201,770
+100,000
+98% +$4.63M
BKNG icon
5
Booking.com
BKNG
$149B
$9.1M 5.02%
183,950
XOM icon
6
ExxonMobil
XOM
$644B
$6.24M 3.44%
83,900
+30,000
+56% +$2.31M
WPM icon
7
Wheaton Precious Metals
WPM
$49.5B
$6.09M 3.36%
506,884
ULTA icon
8
Ulta Beauty
ULTA
$22B
$5.83M 3.21%
35,675
MKC icon
9
McCormick & Company Non-Voting
MKC
$13.7B
$5.04M 2.78%
122,606
CHRW icon
10
C.H. Robinson
CHRW
$17.4B
$4.92M 2.72%
72,636
PAAS icon
11
Pan American Silver
PAAS
$18.2B
$4.86M 2.68%
765,705
ESRX
12
DELISTED
Express Scripts Holding Company
ESRX
$4.64M 2.56%
57,259
HSY icon
13
Hershey
HSY
$35.2B
$4.55M 2.51%
49,504
MSFT icon
14
Microsoft
MSFT
$3.45T
$4.32M 2.38%
97,646
INTC icon
15
Intel
INTC
$455B
$4.29M 2.37%
142,401
MSM icon
16
MSC Industrial Direct
MSM
$6.89B
$3.96M 2.18%
64,870
VAR
17
DELISTED
Varian Medical Systems, Inc.
VAR
$3.96M 2.18%
61,178
ABBV icon
18
AbbVie
ABBV
$443B
-33,000
Closed -$2.22M
ABT icon
19
Abbott
ABT
$183B
-52,137
Closed -$2.56M
BIIB icon
20
Biogen
BIIB
$30B
-3,600
Closed -$1.45M
BSX icon
21
Boston Scientific
BSX
$69.5B
-105,000
Closed -$1.86M
CAH icon
22
Cardinal Health
CAH
$53.9B
-21,000
Closed -$1.76M
CERS icon
23
Cerus
CERS
$433M
-235,000
Closed -$1.22M
DVAX
24
DELISTED
Dynavax Technologies
DVAX
-20,697
Closed -$485K
IQV icon
25
IQVIA
IQV
$38.7B
-25,000
Closed -$1.81M

Similar funds

C Partners Holding's Q3 2015 Portfolio in Review

As of Q3 2015, C Partners Holding held 44 positions worth $181M, down 15% from $213M the previous quarter. Its ten largest holdings account for 83% of the portfolio.

C Partners Holding withdrew a net $8.44M in Q3 2015, closing 26 positions and reducing 1 holding. Its most notable exit was Celgene Corp, an estimated $3.59M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 8.2% of assets, up from 6.6% a quarter earlier, followed by Materials and Consumer Staples.

Against the trend, C Partners Holding opened a new position in Conformis, Inc. Common Stock worth $26.4M.

  • C Partners Holding's largest Q3 2015 buy was Conformis, Inc. Common Stock: 58,506 shares worth $26.4M.
  • C Partners Holding added most to Intercontinental Exchange in Q3 2015, an estimated $4.63M increase.
  • C Partners Holding's biggest Q3 2015 reduction was Adamas Pharmaceuticals, cutting an estimated $3.69M.
  • C Partners Holding fully exited Celgene Corp in Q3 2015, selling an estimated $3.59M.
  • C Partners Holding's ten largest holdings make up 83% of its $181M portfolio in Q3 2015.
  • C Partners Holding opened 1 new position and closed 26 in Q3 2015.
  • C Partners Holding's portfolio value fell 15% quarter-over-quarter to $181M.

Based on C Partners Holding's 13F filing for Q3 2015, filed 12 Nov 2015.